SECTOR
Biocon gets VAI status for Andhra Pradesh’s API facility
Jan-29-2026

Biocon has received a Voluntary Action Indicated (VAI) status from the U.S. Food and Drug Administration (USFDA) for its API facility located in Andhra Pradesh. This is based on an inspection conducted by the agency between November 3, 2025 and November 07, 2025.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

  RELATED NEWS >>